Ikarian Capital, LLC

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1778253 DALLAS, TX

Back to ARWR Full portfolio

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,120,039

+$3,120,039 QoQ

Shares Held

38,278

Ownership

0.027%

of shares outstanding

% of Portfolio

0.50%

of 13F equity value

Holder Rank

#160

of 497 holders

Holding Since

Mar 2020

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARWR Over Time

Shares Held

Position Value (USD)

Derivatives in ARWR

reported options exposure · as of Jun 30, 2026

CallValue

CallShares

PutValue

$8,151,000

PutShares

100,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. ARWR ranks #48 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	328,635	$43,793,900
2	KOD	Kodiak Sciences Inc.	1,059,730	$41,287,080
3	ALMS	Alumis Inc.	870,548	$24,497,220
4	PRAX	Praxis Precision Medicines, Inc.	72,842	$24,386,773
5	PCVX	Vaxcyte, Inc.	388,682	$22,594,084
6	CLDX	Celldex Therapeutics, Inc.	478,500	$17,804,985
7	RCUS	Arcus Biosciences, Inc.	504,559	$15,555,553
8	RLMD	Relmada Therapeutics, Inc.	2,148,359	$14,866,644

All Filings in ARWR

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,151,000	100,000	+73.9%	Put	Sole	2026-08-14
2026-06-30	$3,120,039	38,278	-70.6%	Shares	Sole	2026-08-14
2026-03-31	$3,605,250	57,500	-71.2%	Put	Sole	2026-05-15
2023-06-30	$4,635,800	130,000	—	Shares	Sole	2023-08-14
2020-12-31	$15,346,000	200,000	+2677.8%	Put	Sole	2021-02-12
2020-09-30	$6,459,000	150,000	—	Call	Sole	2020-11-16
2020-03-31	$207,144	7,200	—	Put	Sole	2020-05-15
No filing history on record for this holder in this stock.